Learn more about Chris Boerner, PhD, board chair and chief executive officer at Bristol Myers Squibb. Leading with innovation to deliver vital medicines ...

28.8.2024 · Christopher Boerner, age 53, serves as board chair for Bristol Myers Squibb since April 2024 and chief executive officer since November 2023.

1.11.2023 · Today Chris Boerner begins his new role as our CEO and on April 1, 2024, he'll succeed Giovanni Caforio as Chair of the Board of Directors.

Christopher Boerner is Chief Commercialization Officer of Bristol Myers Squibb, where he leads commercial strategy and execution across all geographies.

By pursuing meaningful work and valuing the people around him, says Chris Boerner, who was recently named board chair and CEO of Bristol Myers Squibb (BMS).

25.4.2024 · Despite layoffs and a hit to earnings, CEO Christopher Boerner was optimistic about the company's prospects in an interview with STAT.

2689 Followers, 1218 Following, 801 Posts - Chris Boerner (@burnoff) on Instagram: "Guitarist, Producer, Mixer, Mastering Engineer"

CHRISTOPHER BOERNER is currently the president and head of the U.S. commercial business at Bristol-Myers Squibb. He joined BMS in February 2015.

17.11.2023 · CEO Chris Boerner and SVP Cathi Ahearn, Worldwide Commercial Portfolio Strategy, discussed the importance of gender equity, advocacy and ...

Chris Boerner is Chief Executive Officer at Bristol-Myers Squibb Co. See Chris Boerner's compensation, career history, education, & memberships.